• OPEN AN ACCOUNT
Indian Indices
Nifty
24,967.75 97.65
(0.39%)
Sensex
81,635.91 329.06
( 0.40%)
Bank Nifty
55,139.30 -10.10
( -0.02%)
Nifty IT
36,280.10 839.25
( 2.37%)
Global Indices
Nasdaq
45,658.64 852.13
(1.90%)
Dow Jones
6,488.44 97.27
(1.52%)
Hang Seng
42,789.96 156.67
(0.37%)
Nikkei 225
9,321.40 12.20
(0.13%)
Forex
USD-INR
87.17 0.12
(0.14%)
EUR-INR
101.39 0.01
(0.01%)
GBP-INR
117.16 -0.12
(-0.11%)
JPY-INR
0.59 0.00
(-0.18%)

EQUITY - MARKET SCREENER

Oriental Infra Trust
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
535371
INE07Z523018
84.8440208
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
OSEINTRUST
0
0
EPS(TTM)
Face Value()
Div & Yield %
7.78
100
0
 

mangalam organics ltd
Concord Biotech's API unit in Limbassi concludes EU-GMP inspection
Aug 21,2025
Concord Biotech announced that the European Union Good Manufacturing Practice (EU-GMP) authorities have conducted their first inspection of its Active Pharmaceutical Ingredients (API) manufacturing facility located at Limbassi. The inspection was carried out from 18 August 2025 to 21 August 2025.

'This milestone marks a significant achievement for Concord, as a successful EU-GMP inspection not only validates our commitment to global quality standards but also paves the way for expanding our footprint into new international markets. The approval will enable Concord to explore commercial opportunities across various EU territories and other regulated geographies, strengthening our global presence and growth trajectory,' said the company.